The merger of bioprinting and microfluidics opens the door for on-demand and personalized organ-on-a-chip models and could be used in preclinical stages of drug trials. In this presentation, Cecilia Soto, an application specialist at CELLINK,  discusses how 3D bioprinting technologies can be used for microfluidic applications.